Halozyme Therapeutics, Inc. (HALO) Social Stream
HALOZYME THERAPEUTICS INC (HALO) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering HALOZYME THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-03 | 10 | $62 | $19 | $49.444 | $36.55 | 35.28% |
| 2021-11-24 | 10 | $62 | $19 | $49.125 | $36.55 | 34.4% |
| 2022-01-26 | 8 | $62 | $19 | $48.857 | $36.55 | 33.67% |
| 2022-02-23 | 8 | $62 | $19 | $48.571 | $36.55 | 32.89% |
| 2022-05-11 | 8 | $62 | $19 | $49.428 | $36.55 | 35.23% |
| 2022-05-13 | 8 | $62 | $19 | $49.142 | $36.55 | 34.45% |
| 2022-05-23 | 9 | $62 | $19 | $49.5 | $36.55 | 35.43% |
| 2022-05-26 | 8 | $60 | $19 | $49.25 | $36.55 | 34.75% |
| 2022-06-06 | 9 | $62 | $19 | $50.666 | $36.55 | 38.62% |
| 2022-08-10 | 7 | $60 | $21 | $50 | $36.55 | 36.8% |
| 2022-08-15 | 8 | $60 | $21 | $50 | $36.55 | 36.8% |
| 2022-10-26 | 8 | $60 | $21 | $49.375 | $36.55 | 35.09% |
| 2022-11-08 | 9 | $60 | $21 | $49.375 | $36.55 | 35.09% |
| 2022-11-14 | 9 | $62 | $23 | $52.444 | $36.55 | 43.49% |
| 2022-11-22 | 9 | $62 | $23 | $52.555 | $36.55 | 43.79% |
| 2022-11-28 | 9 | $65 | $23 | $53.333 | $36.55 | 45.92% |
| 2022-12-08 | 9 | $68 | $23 | $54.777 | $36.55 | 49.87% |
| 2022-12-21 | 9 | $68 | $23 | $56.111 | $36.55 | 53.52% |
| 2023-01-11 | 9 | $68 | $23 | $56 | $36.55 | 53.21% |
| 2023-02-22 | 9 | $68 | $26 | $56.333 | $36.55 | 54.13% |
| 2023-02-23 | 9 | $68 | $26 | $56.555 | $36.55 | 54.73% |
| 2023-03-03 | 9 | $68 | $26 | $56.444 | $36.55 | 54.43% |
| 2023-04-20 | 9 | $68 | $26 | $54.333 | $36.55 | 48.65% |
| 2023-05-10 | 8 | $68 | $26 | $53.625 | $36.55 | 46.72% |
| 2023-07-24 | 10 | $68 | $26 | $53.5 | $36.55 | 46.37% |
| 2023-08-09 | 10 | $68 | $26 | $53.4 | $36.55 | 46.1% |
| 2023-08-10 | 10 | $68 | $28 | $53.9 | $36.55 | 47.47% |
| 2023-08-14 | 10 | $68 | $28 | $54.4 | $36.55 | 48.84% |
| 2023-10-09 | 10 | $68 | $28 | $53.1 | $36.55 | 45.28% |
| 2023-10-19 | 10 | $68 | $28 | $53.2 | $36.55 | 45.55% |
| 2023-10-27 | 10 | $66 | $28 | $51.4 | $36.55 | 40.63% |
| 2023-11-07 | 11 | $66 | $28 | $50.636 | $36.55 | 38.54% |
The Trend in the Analyst Price Target
HALO's average price target has moved up $22.64 over the prior 42 months.
HALO reports an average of 39.94% for its upside potential over the past 43 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-22 | 9 | 68 | 26 | 56.333 | 50.08 | 12.49% |
| 2023-02-23 | 9 | 68 | 26 | 56.555 | 50.35 | 12.32% |
| 2023-05-10 | 8 | 68 | 26 | 52.875 | 34.49 | 53.31% |
| 2023-10-19 | 10 | 68 | 28 | 53.200 | 35.80 | 48.6% |
| 2023-11-07 | 11 | 66 | 28 | 50.636 | 38.80 | 30.51% |
HALO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.64 | 8 | 0 | 2 | 0 | 0 | 11 |
The Trend in the Broker Recommendations
Over the past 14 months, HALO's average broker recommendation rating improved by 0.03.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- HALOZYME THERAPEUTICS INC's variance in analysts' estimates is lower than -3898.11% of all US stocks.
- HALOZYME THERAPEUTICS INC's average analyst price target is greater than 3425.72% of Pharmaceutical Products stocks.
- In terms of how HALOZYME THERAPEUTICS INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1505.76% of that group.
- HALOZYME THERAPEUTICS INC's number of analysts covering the stock is higher than 3095.13% of stocks in the mid market cap category.
Stocks similar to HALOZYME THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are BCRX, SNDL, and USNA.
View All Top Stocks by Price Target
What is the outlook for HALO? Use POWR Ratings for clearer insight into price direction.